Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry.
Myomo
Post IPO Debt • Cambridge, United States
Stryker
Kalamazoo, United States
Integra LifeSciences
Post IPO Equity • NJ, United States
Align Technology
Series D • San Jose, United States
Envista
Post IPO Debt • Brea, United States
Boston Scientific
Marlborough, United States
Smith & Nephew
England, United Kingdom
Baxter
Deerfield, United States
Becton Dickinson
Franklin Lakes, United States
3Shape
Private Equity • København, Denmark
Dimension Inx
Venture • Chicago, United States
Intuitive Surgical
CA, United States